CANY
XLRN

Caxton Associates (New York)’s Acceleron Pharma Inc. XLRN Stock Holding History

Caxton Associates (New York)’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,924
Closed -$331K – 674
2021
Q3 		$331K Buy
+1,924
New +$331K 0.04% 275